Leukapheresis Market worth $100 million by 2028
The Global Leukapheresis Products Market was estimated to be worth USD 70 million in 2023 and is poised to reach USD 100 million by 2028, growing at a CAGR of 8.3%. The global leukopaks market was estimated to be worth USD 200 million in 2023 and is poised to reach USD 1020 million by 2028, growing at a CAGR of 38.1%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148
Leukapheresis...
Leukapheresis Market Globally Grow at a CAGR of 8.4% by Revenue During the Period
According to the new market research report “Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) – Global Forecast to 2026″, published by MarketsandMarkets™, the global Leukapheresis Products Market is projected to reach...
Leukapheresis Market Market 2018 Worldwide By Key Players – Fresenius (Germany), Haemonetics (US), Terumo BCT (US)
The market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.
According to a new market research report “Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute)...
Increasing Adoption of Therapeutic Leukapheresis Procedures to Drive Market Growth
The global leukapheresis products market is projected to reach USD 27.7 million by 2023 from USD 19.4 million in 2018, at a CAGR of 7.4%.
Leukapheresis involves the separation of white blood cells from whole blood. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. Leukopaks are regularly used in research settings and in cell therapy process development....